NYSE
$17.73▲ 0.34%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $539.1MShares out 30.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
4- 10.14Regular26.10.14 22:42SCHEDULE 13G/AOwnership#●●●
abrdn Life Sciences Investors
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have filed a Schedule 13G/A regarding their joint beneficial ownership of abrdn Life Sciences Investors (HQL). This filing confirms their agreement to report their equity holdings jointly in accordance with Rule 13d-1(k)(1) of the Securities Exchange Act of 1934.…more
$17.73+0.34%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.24Regular26.09.24 22:4640-17GOther
abrdn Life Sciences Investors
abrdn Life Sciences Investors and other funds within the abrdn complex have entered into a joint Financial Institution Bond, effective from May 14, 2026, through May 14, 2027. This filing serves as a formal notification to the SEC regarding the insurance coverage and board resolutions pursuant to Rule 17g-1 of the Investment Company Act of 1940.…more
$17.73+0.34%vs prev closeView filingShare - 8.28Regular26.08.29 00:24NPORT-POther
abrdn Life Sciences Investors
As of June 30, 2026, abrdn Life Sciences Investors holds a total portfolio value of $689.62 million. The fund's investments consist of 87.5% in common stocks, alongside holdings in convertible preferred stocks, convertible notes, and warrants, primarily focused on the biotechnology and pharmaceutical sectors.…more
$17.73+0.34%vs prev closeView filingShare
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.